Scientists & Doctors
At VIVA, we believe that scientists and doctors are the driving force behind cures and hope for children with cancer.
Our mission to save lives is made possible through their dedication, expertise, and relentless pursuit of discovery.
These individuals are the key intermediaries between our vision and our ultimate beneficiaries – the children and families affected by cancer.
Professor, Department of Paediatrics, Yong Loo Lin School of Medicine, National University of Singapore
Mrs Lee Kong Chian Chair in Advanced Cellular Therapy
Professor Dario Campana obtained his MD from the University of Torino and his PhD from the University of Milano, Italy. Before joining St. Jude Children’s Research Hospital in Memphis, he was a Lecturer in Immunology at the Royal Free Hospital, University of London (UK). At St. Jude, he served as Vice Chair for Laboratory Research in the Department of Oncology and Professor of Paediatrics at the University of Tennessee.
Currently based at NUS, Professor Campana’s research focuses on cancer immunotherapy, including immune-cell engineering and minimal residual disease detection in leukaemia. He has published over 300 papers and holds multiple patents advancing cellular therapy worldwide.
VIVA–Goh Foundation Professor in Paediatric Oncology, Yong Loo Lin School of Medicine, NUS
Head and Senior Consultant, Division of Paediatric Haematology and Oncology, National University Hospital
Professor Allen Yeoh is the principal investigator of the Malaysia–Singapore ALL and AML trials, achieving projected cure rates exceeding 80% and 60%, respectively. His work focuses on childhood leukaemia, risk-stratification biomarkers, and precision therapy.
He leads the VIVA–NUS Centre for Translational Research in Acute Leukaemia (CenTRAL), integrating genomics and MRD technologies to guide clinical management. Together with Professor Campana, he co-leads the CAR-T Cell Programme at NUHS.
Professor Yeoh was the first Singaporean to receive the American Society of Hematology Merit Award and has been honoured with the Singapore Youth Award, Asian Innovation Award (Gold), and the National Outstanding Clinician Scientist Award.
Deputy Chief Executive Officer (Clinical), National Neuroscience Institute (NNI), Singapore
Senior Consultant, Department of Neurosurgery, NNI
Clinical Associate Professor, Duke–NUS Medical School
Adj Clinical Prof David Low is a neurosurgeon specialising in paediatric neurosurgery, neuro-oncology (brain tumour surgery), epilepsy surgery and hydrocephalus.
He obtained his MBBCh from the Royal College of Surgeons in Ireland (2000), MRCS (Edinburgh), MMed (Surgery, NUS), and FRCS (Edinburgh). He completed a Ministry of Health HMDP fellowship in Paediatric Neurosurgery at The Hospital for Sick Children, Toronto (2011).
He previously served as Head of Neurosurgery at KK Women’s and Children’s Hospital and Program Director for the SingHealth Neurosurgical Residency Programme (2013–2019). He later became Head of Department, Neurosurgery at NNI@TTSH (2019–2023) before assuming his current role as Deputy CEO (Clinical) at NNI.
Prof Low continues to train future neurosurgeons and lead clinical and academic programmes within the SingHealth–Duke-NUS Neuroscience Academic Clinical Programme.
Senior Consultant, Department of Paediatric Surgery
Deputy Chair, Division of Surgery, KK Women’s and Children’s Hospital Singapore
Dr Amos Loh obtained his medical degree from the National University of Singapore in 2002 and went on to train in general surgery and then paediatric surgery and was awarded the College of Surgeons Gold Medal in paediatric surgery in 2011. He trained as a fellow in paediatric surgical oncology at St Jude Children’s Research Hospital and was awarded a National Medical Research Council research training award for his research fellowship in the lab of Michael Dyer, PhD.
He is presently Deputy Chair of the Division of Surgery and a Senior Consultant with the Department of Paediatric Surgery, KK Women’s and Children’s Hospital (KKH), with a clinical practice and academic research focus in paediatric surgical oncology. Dr Loh’s areas of interest are clinical and translational research in paediatric solid tumours. In particular, his lab focuses on the development of models of paediatric solid tumours for preclinical development of novel therapeutics, and the discovery of biomarkers for prognostication and therapeutic stratification of paediatric solid tumours.
He chairs the VIVA-KKH Paediatric Brain and Solid Tumour Programme, a multi-institution collaboration that brings together clinicians and scientists to cooperate on advancing the care and research of paediatric brain and solid tumours in Singapore.
Head & Senior Consultant Haematology/Oncology Service
Paediatric Brain and Solid Tumour Programme, KK Women’s and Children’s Hospital Singapore
Dr Soh Shui-Yen is the Head and Senior Consultant from the Paediatric Haematology/Oncology Service of KK Women’s and Children’s Hospital (KKH) in Singapore. Dr Soh graduated from the Faculty of Medicine, National University of Singapore (NUS). She received her Paediatric Medicine training in Singapore and also completed 1 year of Paediatric Oncology clinical fellowship at the Hospital of Sick Children in Toronto, Canada.
Her academic interests are in paediatric brain and solid tumours, as well as in cellular and immunotherapies in cancer. She is currently the Chair of the Paediatric Oncology Group Singapore and a steering committee member of the VIVA-KKH Paediatric Brain and Solid Tumour Programme.
She also holds teaching appointments with the NUS Yong Loo Lin School of Medicine, the Duke-NUS Graduate School of Medicine, the National Technological University (NTU) – Lee Kong Chian (LKC) School of Medicine and the SingHealth Paediatrics Residency Programme.
Consultant, Division of Paediatric Haematology and Oncology, National University Hospital
Adjunct Assistant Professor, Department of Paediatrics, Yong Loo Lin School of Medicine, NUS
Dr Shawn Lee graduated with MBBS from Yong Loo Lin School of Medicine, NUS in 2011 where he was awarded the Wong Poi Kwong Medal for Clinical Medicine. He went on to obtain his Master of Medicine (Paeds) and MRCPCH (UK) in 2015. In 2017, he was awarded the Exxon-Mobil Fellowship for Clinicians and also received the MOH Healthcare Scholarship for his Master of Clinical Investigation (MCI) which he obtained in 2019.
He was subsequently awarded the NMRC Research Training Fellowship in 2019 where he embarked on a 3-year fellowship in leukemia genomics under Dr Yang Jun in St Jude Children’s Hospital in Memphis, USA. In 2021, he was awarded the American Association for Cancer Research (AACR) Scholar-In-Training Award and Society of Hematologic Oncology Young Investigator Award for his work on genomic diversity of childhood leukemia.
His research interests include individualised therapy in oncology, specifically pharmacogenomics to allow for tailoring of treatment therapy, and also immunogenomics to aid in prognostication, risk stratification and optimal utilisation of CAR-T and other immunotherapeutic agents.
Honorary Clinical Assistant Professor, Department of Paediatrics & Adolescent Medicine, LKS Faculty of Medicine, The University of Hong Kong
Staff Oncologist, Pediatric Brain Tumour Program, The Hospital for Sick Children, Toronto, Canada
Dr Anthony Liu joined the staff at The Hospital for Sick Children (SickKids) in 2024. Dr Liu obtained his Medical Degree with Honours from the University of Hong Kong, and completed his Paediatric and Paediatric Haematology/Oncology training in Queen Mary Hospital, Hong Kong. Subsequently, he pursued a Clinical and Research Fellowship in Paediatric Neuro-Oncology at St. Jude Children’s Research Hospital, spearheading landmark studies on circulating tumour DNA analysis for medulloblastoma and molecular profiling in rare CNS embryonal tumours.
Before his transition to Toronto, Dr Liu served as attending Paediatric Haematologist/Oncologist at Hong Kong Children’s Hospital, dedicating effort in parallel for capacity building in Paediatric Neuro-Oncology with providers from Asia.
Head, Department of Pathology and Laboratory Medicine, KK Women’s and Children’s Hospital
Adjunct Associate Professor, Duke–NUS Medical School
Adjunct Associate Professor Kenneth Chang is Deputy Chairman of the Division of Clinical Support Services and Senior Consultant Pathologist and Head of Molecular Pathology at the Department of Pathology and Laboratory Medicine at KK Women’s and Children’s Hospital in Singapore. He is Clinical Associate Professor at Duke-NUS Medical School, and Academic Vice-Chair for Clinical Service Transformation in the SingHealth Duke-NUS Pathology Academic Clinical Programme.
Within the SingHealth cluster, he is Director of the SingHealth Tissue Repository and Advanced Molecular Pathology Laboratory. He is the programme lead of the St Jude-KKH Asia-Pacific Paediatric Pathology Programme, a regional paediatric pathology programme supported by St Jude Children’s Research Hospital, focused on capacity building for paediatric oncological pathology amongst a network of children’s hospitals in Asia.
He is also Visiting Professor at the Shanghai Children’s Medical Centre/Jiao Tong University, in Shanghai, People’s Republic of China. Kenneth is an editorial board member of Pediatric and Developmental Pathology.
Senior Consultant, Children’s Blood and Cancer Centre, Department of Paediatric Haematology and Oncology, KK Women’s and Children’s Hospital
Duke-NUS Medical School
Dr Michaela Seng is a Paediatric haematologist and oncologist in KK Women’s and Children’s Hospital who holds full specialist accreditation in both Australia and Singapore. She currently serves as the BMTCT Clinical Facility medical director and research lead in the KK Women’s and Children’s Blood and Cancer Centre.
Her research interest is in the translation of innovative cell therapies for relapsed refractory cancers, motivated by the treatment failures and toxicities seen in her practice. In this regard, she runs several investigator-initiated cell therapy trials for adult and paediatric patients as the Principle Investigator.
Consultant, Division of Paediatric Haematology and Oncology, Department of Paediatrics
Khoo Teck Puat – National University Children’s Medical Institute, National University Hospital
Dr Frances Yeap graduated from St Bartholomew’s and The Royal London School of Medicine and Dentistry and returned to Singapore to complete her training in Paediatrics. Her clinical practice at the National University Hospital encompasses General Paediatrics and all aspects of Paediatric Haematology and Oncology.
She has a special interest and expertise in Bone Marrow Transplant, particularly in transplants for non-malignant conditions and immunodeficiencies. Alongside her clinical work, Dr Yeap is actively involved in research focused on the genomics and molecular pathogenesis of childhood leukaemia, contributing to the development of precision medicine approaches for patients in Singapore and the region.
Independent Contractor, St Jude Global Alliance Asia Pacific Regional Program
Project Consultant, Division of Paediatric Oncology, Department of Paediatrics, Yong Loo Lin School of Medicine, National University of Singapore
Global Co-Ordinator, Vietnam Pediatric Hematology Oncology Program
Dr Sally Blair holds an MBBS and MPH from the University of Sydney. She trained at The Children’s Hospital at Westmead, Australia, before moving to Singapore in 2007. Since then, she has been actively involved in regional and international paediatric oncology initiatives, including the St. Jude–VIVA Forum in Paediatric Oncology.
In her role with St. Jude Global, she focuses on building capacity and improving care standards for children with cancer and blood diseases across the Asia Pacific region.
Learn more about the doctors and researchers from the VIVA–KKH Paediatric Brain and Solid Tumour Programme at www.kkh.com.sg
